Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 7Leukemia, Myeloid, Acute 7Leukemia 7Multiple Myeloma 6Lymphoma 6Lymphoma, Non-Hodgkin 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Myeloproliferative Disorders 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Myeloid, Accelerated Phase 2Hodgkin Disease 2Blast Crisis 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Preleukemia 1Polycythemia Vera 1Paraproteinemias 1Non-Malignant Neoplasm 1Neoplasms, Plasma Cell 1Lymphoproliferative Disorders 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Biphenotypic, Acute 1

Interventions

Cyclophosphamide 5fludarabine 3fludarabine phosphate 2Mesna 2Antigens, CD19 2navitoclax 1ibrutinib 1bempegaldesleukin 1acalabrutinib 1Vincristine 1Stem Cell Transplantation 1Rituximab 1Prednisone 1Nivolumab 1Mycophenolic Acid 1Melphalan 1Lenalidomide 1KW-2478 1Interleukin-2 1Hsp90 inhibitor KU757 1Filgrastim 1Doxorubicin 1CTL019 chimeric antigen receptor 1Bortezomib 1Bone Marrow Transplantation 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, B-Cell × Stem Cell Transplantation × Clear all
NCT01517035 2018-07-05

Improving Blood Stem Cell Collection and Transplant Procedures

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
43 enrolled
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡